FRESH-PEF3319-en
SU.FOL.OM3 Trial: B-vitamins and N-3 polyunsaturated fatty acids supplementation and risk of recurrence of cardiovascular events
SU.FOL.OM3
| Name | Country code |
|---|---|
| France | fr |
['Clinical data','Biological data','Participant-reported health data']
Individuals
| Topic | Vocabulary |
|---|---|
| Cardiology and vascular medicine | health theme |
| Ischaemic heart diseases | cim-11 |
| Diseases of the circulatory system | cim-11 |
| Socio-demographic and economic determinants | health determinant |
| Behavioral determinants: Eating habits | health determinant |
| Healthcare system determinants: Use of care | health determinant |
| Behavioral determinants | health determinant |
| Healthcare system determinants | health determinant |
{"level_sex_clusion_I":[{"value":"Male","concept":{"vocab":"MeSH","vocabURI":"D008297"}},{"value":"Female","concept":{"vocab":"MeSH","vocabURI":"D005260"}}],"level_age_clusion_I":[{"value":"Middle Aged (45 to 64 years)","concept":{"vocab":"MeSH","vocabURI":"D008875"}},{"value":"Aged (65 to 79 years)","concept":{"vocab":"MeSH","vocabURI":"D000368"}}],"level_type_clusion_I":"Patients population","level_type_clusion_other":"","clusion_I":"Subjects aged between 45 and 80, having presented a myocardial infarction, unstable angina or stroke in the period preceding their inclusion (event occurred at least one month and at the most one year prior to inclusion). ","clusion_E":"subjects that have to take B12, folic acid or B6 supplements, subjects under methotrexate treatment, subjects suffering from a life-threatening non-cardiovascular disease over the 5 years of the study, severe chronic kidney disease sufferers."}
| Name |
|---|
| Pilar;GALAN |
| Serge;HERCBERG |
| Name | Role |
|---|---|
| INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) | sponsor |
| INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE L'ALIMENTATION ET L'ENVIRONNEMENT (INRAE) | sponsor |
| UNIVERSITE SORBONNE PARIS NORD | sponsor |
| CONSERVATOIRE NATIONAL DES ARTS ET METIERS (CNAM) | sponsor |
| Name |
|---|
| CANDIA (C.SAS) |
| DANONE |
| INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) |
| MERCK SANTE |
| MINISTERE DE L’ENSEIGNEMENT SUPERIEUR, DE LA RECHERCHE ET DE L’ESPACE |
| PIERRE FABRE (FRANCE) |
| Agency name |
|---|
| CNIL |
| CPP |
['Through organizations (health services or institutions, schools, businesses, etc.)','Through independent healthcare practitioners']
['{"concept":{"vocabURI":"Other","vocab":"CESSDA"},"value":"Other"}']
Access on specific project only
Observational Study
| Start | End |
|---|---|
| 2003-01-01 | 2010-01-01 |
['Coherency query during and after entry of computer data.Management of missing data by return to source file or return to patient.Reminders sent out to physicians for follow-up appointments.Reminders sent out to subjects for follow-up appointments.Internal quality audit performedThe patients are informed of what use will be made of their data.']
Involvement in a cohort network: network of trials on intervention by folates (55 000 SJ au TAL)
{"value":"Restricted access","extLink":[{"title":"COAR","uri":"http://purl.org/coar/access_right/c_16ec"}]}
Possible use of data by academic teams (contractual conditions) Data cannot be used by manufacturers
| Name | |
|---|---|
| Pilar;GALAN | p.galan@eren.smbh.univ-paris13.fr |
| Serge;HERCBERG | s.hercberg@eren.smbh.univ-paris13.fr |